MAKE AMERICANS SEE AGAIN

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 25 Jun 2025 filing date already counts against anyone who files later.

Record

Serial number

99252473

Mark type

Stylized text

Filed

25 Jun 2025

Published for opposition

09 Dec 2025

Attorney of record

Don Cha

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical preparations for gene therapy for the treatment of retinal diseases
• Class 035 — Advertising and business services: Online advertising and marketing services in the field of ophthalmology; On-line advertising and marketing services
• Class 042 — Scientific and technological services: Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology; Biotechnology research; Product research; Scientific research; Medical research; Biological research; Providing medical research information in the field of pharmaceuticals; Providing scientific research information in the field of pharmaceuticals; Research and development services in the field of biotechnology; Research in the field of DNA repair technology; Providing information about medical and scientific research via a website; Biochemical research and analysis; Research and development of vaccines and medicines; Research and development in the field of biochemistry; Research and development in the field of biotechnology; Medical research in the field of rare diseases; Biochemical research; Research and development of medicines; Research and development in the pharmaceutical and biotechnology fields; Research on the subject of pharmaceuticals; Research and development of new products; Gene therapy research; Pharmaceutical research and development; Vaccine research and development; Clinical research in the field of ophthalmology; Scientific study and research in the field(s) of ophthalmology; Pharmaceutical research in the field of ophthalmology; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; Development of pharmaceuticals for cell and gene therapies
• Class 044 — Medical, beauty and agricultural services: Ophthalmology services; Providing on-line medical record analysis services designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; Providing on-line information, news and commentary in the field of health and wellness relating to ophthalmology

Owner

• OCUGEN, INC., MALVERN, PA, US
• OCUGEN, INC., MALVERN, PA, US

Prosecution history

• 03 Feb 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 09 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 09 Dec 2025 — PUBLISHED FOR OPPOSITION
• 03 Dec 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 13 Nov 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 13 Nov 2025 — ASSIGNED TO EXAMINER
• 31 Oct 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 25 Jun 2025 — APPLICATION FILING RECEIPT MAILED
• 25 Jun 2025 — NEW APPLICATION ENTERED